Waters (WAT)
Waters Corporation, the world's leading specialty measurement company, has pioneered chromatography, mass spectrometry, and thermal analysis innovations serving the life, materials, and food sciences for more than 60 years. With more than 7,000 employees worldwide, Waters operates directly in 35 countries, including 15 manufacturing facilities, and with products available in more than 100 countries.
Company profile
Ticker
WAT
Exchange
Website
CEO
Christopher O'Connell
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
Agilent • Perkinelmer • Bio-Rad Laboratories • Avantor • Illumina • Mettler-Toledo International • Bruker • Coherent • Seer • Cue Health ...
SEC CIK
Corporate docs
Subsidiaries
Waters Technologies Corporation • Andrew Alliance SA • Environmental Resource Associates, Inc. • Integrated Software Solutions Pty Limited • Integrated Software Solutions Limited • Integrated Software Solutions USA, LLC • TA Instruments-Waters LLC • Waters AG • Waters Australia PTY LTD. • Waters India Pvt. Ltd. ...
IRS number
133668640
WAT stock data
News
Benzinga's Top Ratings Upgrades, Downgrades For May 17, 2022
17 May 22
B of A Securities Upgrades Waters to Neutral, Raises Price Target to $330
17 May 22
Why Waters Corp Shares Are Surging Today
3 May 22
Recap: Waters Q1 Earnings
3 May 22
Waters Q1 EPS $2.80 Beats $2.32 Estimate, Sales $690.57M Beat $632.75M Estimate
3 May 22
Press releases
Waters and University of Delaware Announce Official Opening of Immerse Delaware Lab
5 May 22
Waters Corporation (NYSE: WAT) Reports First Quarter 2022 Financial Results
3 May 22
Waters Corporation to Host Investor Day
19 Apr 22
Waters Corporation Q1 2022 Financial Results Webcast Invitation
7 Apr 22
Waters Introduces Xevo TQ Absolute – The Most Sensitive and Compact Benchtop Tandem Quadrupole Mass Spectrometer
31 Mar 22
Analyst ratings and price targets
Calendar
5 May 22
17 May 22
31 Dec 22
Financial summary
| Quarter (USD) | Apr 22 | Dec 21 | Oct 21 | Jul 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 480.07M | 480.07M | 480.07M | 480.07M | 480.07M | 480.07M |
| Cash burn (monthly) | 7.05M | 16.98M | (no burn) | (no burn) | (no burn) | (no burn) |
| Cash used (since last report) | 10.61M | 25.54M | n/a | n/a | n/a | n/a |
| Cash remaining | 469.46M | 454.53M | n/a | n/a | n/a | n/a |
| Runway (months of cash) | 66.5 | 26.8 | n/a | n/a | n/a | n/a |
Recent insider trades
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 12 May 22 | Chaubal Amol | Common Stock | Payment of exercise | Dispose F | No | No | 313.95 | 145 | 45.52K | 2,325 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Sell | Dispose S | No | No | 335.525 | 1,352 | 453.63K | 2,283 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Sell | Dispose S | No | No | 334.508 | 1,601 | 535.55K | 3,635 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Sell | Dispose S | No | No | 335.96 | 1,237 | 415.58K | 5,236 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Sell | Dispose S | No | No | 335.188 | 523 | 175.3K | 6,473 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Sell | Dispose S | No | No | 337.5 | 1,249 | 421.54K | 6,996 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Option exercise | Acquire M | No | No | 335.5 | 1,352 | 453.6K | 8,245 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Option exercise | Acquire M | No | No | 334.05 | 1,601 | 534.81K | 6,893 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Option exercise | Acquire M | No | No | 335.7 | 1,760 | 590.83K | 5,292 |
| 5 May 22 | Hendrickson Gary E | Common Stock | Option exercise | Acquire M | No | No | 337.51 | 1,249 | 421.55K | 3,532 |
Institutional ownership, Q4 2021
83.1% owned by funds/institutions
| 13F holders | Current |
|---|---|
| Total holders | 649 |
| Opened positions | 94 |
| Closed positions | 86 |
| Increased positions | 190 |
| Reduced positions | 229 |
| 13F shares | Current |
|---|---|
| Total value | 18.64B |
| Total shares | 50.05M |
| Total puts | 68.9K |
| Total calls | 126.34K |
| Total put/call ratio | 0.5 |
| Largest owners | Shares | Value |
|---|---|---|
| Vanguard | 6.66M | $2.48B |
| BLK Blackrock | 6.07M | $2.26B |
| BK Bank Of New York Mellon | 4.05M | $1.51B |
| STT State Street | 2.78M | $1.04B |
| Massachusetts Financial Services | 2.55M | $948.79M |
| FMR | 1.39M | $518.42M |
| Geode Capital Management | 1.18M | $439.99M |
| Champlain Investment Partners | 972.74K | $362.44M |
| IVZ Invesco | 969.12K | $361.09M |
| JHG Janus Henderson | 928.88K | $346.1M |
Financial report summary
?Competition
Perkinelmer • General Electric • Thermo Fisher Scientific • Danaher • Mettler-Toledo International • Agilent • Bruker • Spectris • 908 Devices • Merck KGaAContent analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. sophomore Avg
|
|
New words:
analyze, attempt, cell, charge, conflict, conventional, COVID, electronic, escalation, extend, extremely, freight, gene, geopolitical, inflationary, instability, introduced, Korea, Megadalton, milestone, newly, pronouncement, prospectively, protein, public, put, Russia, Topic, Ukraine, Unregistered, war
Removed:
Alliance, allocation, amending, Andrew, approach, began, Bruker, build, calculating, clarifying, committed, comparability, consistent, construction, Daltronik, dated, decline, deficit, deliver, depending, diagnostic, economy, enacted, equip, executed, expanding, external, favorably, fluid, France, franchise, geographical, GmbH, havea, innovation, interaction, intraperiod, joint, laboratory, lease, letter, methodology, notice, November, organizational, pace, ramped, realized, recently, recover, reduction, reinstated, relevance, removing, resolve, restructuring, resulted, resuming, salary, SASU, saving, settled, settlement, step, sufficient, termination, timsTOF, unpredictability, unsettled, USA, written
Financial reports
Current reports
8-K
Sales of $691 million grew 13% as reported and 16% in constant currency
3 May 22
8-K
Departure of Directors or Certain Officers
1 Apr 22
8-K
Fourth quarter sales of $836 million grew 8% in constant currency, 6% as reported
1 Feb 22
8-K
Regulation FD Disclosure
10 Jan 22
8-K
Sales of $659 million grew 11% as reported and in constant currency
2 Nov 21
8-K
Waters Corporation Appoints John M. Ballbach to Board of Directors
6 Oct 21
8-K
Entry into a Material Definitive Agreement
20 Sep 21
8-K
Sales of $682 million grew 31% as reported and 27% in constant currency
3 Aug 21
8-K
Waters Corporation Appoints Wei Jiang to Board of Directors
24 Jun 21
8-K
Submission of Matters to a Vote of Security Holders
12 May 21
Registration and prospectus
S-8 POS
Registration of securities for employees (post-effective amendment)
8 Jun 20
S-8
Registration of securities for employees
8 Jun 20
15-12B
Securities registration termination
23 Apr 13
25-NSE
Exchange delisting
8 Apr 13
S-8
Registration of securities for employees
4 Sep 12
S-8
Registration of securities for employees
9 Jul 09
S-8
Registration of securities for employees
12 Oct 06
S-3ASR
Automatic shelf registration
25 May 06
S-8
Registration of securities for employees
19 Nov 03
8-A12B/A
Registration of securities on exchange (amended)
26 Aug 02
Proxies
DEFA14A
Additional proxy soliciting materials
14 Apr 22
DEFA14A
Additional proxy soliciting materials
1 Apr 21
DEFA14A
Additional proxy soliciting materials
2 Apr 20
DEFA14A
Additional proxy soliciting materials
4 Apr 19
DEF 14A
Definitive proxy
28 Mar 18
DEFA14A
Additional proxy soliciting materials
28 Mar 18
Other
SD
Conflict minerals disclosure
26 May 21
SD
Conflict minerals disclosure
27 May 20
SD
Conflict minerals disclosure
8 May 19
SD
Conflict minerals disclosure
2 May 18
SD
Conflict minerals disclosure
24 May 17
UPLOAD
Letter from SEC
27 Jun 16
CORRESP
Correspondence with SEC
26 Jun 16
UPLOAD
Letter from SEC
16 Jun 16
CORRESP
Correspondence with SEC
31 May 16
SD
Conflict minerals disclosure
24 May 16
Ownership
4
WATERS / Amol Chaubal ownership change
13 May 22
4/A
WATERS / Gary E Hendrickson ownership change
9 May 22
4
WATERS / Gary E Hendrickson ownership change
9 May 22
4
WATERS / MICHAEL F SILVEIRA ownership change
4 May 22
4
WATERS / Jonathan M Pratt ownership change
4 May 22
SC 13G/A
WATERS / BlackRock ownership change
8 Apr 22
4
WATERS / Jianqing Bennett ownership change
6 Apr 22
4
WATERS / Wei Jiang ownership change
4 Apr 22
4
WATERS / Pearl S Huang ownership change
4 Apr 22
4
WATERS / Gary E Hendrickson ownership change
4 Apr 22
Patents
Utility
Multi-dimensional chromatographic system for analyzing multiple sample components
17 May 22
A chromatography system includes a first chromatography column for receiving and separating a flow stream, a plurality of traps configured to trap a plurality of distinct flow segments exiting the first chromatography column during separation of the flow stream, and a second chromatography column operatively associated with the plurality of traps for receiving and separating the distinct flow segments.
Utility
Chemical class compositions from collision cross-section fragment ions
17 May 22
The present disclosure generally relates to methods for determining chemical class compositions present in a sample using collision cross-section fragment ion values.
Utility
Methods and Compositions Useful for Nucleic Acid Analysis
12 May 22
The present disclosure relates to compositions that comprise a fluorescent and/or MS-active nucleic acid probe that comprises (a) a nucleic-acid-based moiety and (b) a fluorescent moiety comprising a fluorophore, an MS-active moiety, or both a fluorescent moiety and an MS-active moiety, linked to the nucleic-acid-based moiety, among other aspects.
Utility
Variable fluidic restrictor having selective restriction
10 May 22
A variable fluidic restrictor of a liquid chromatography system including a stator body, the stator body include a plurality of fluidic channels located within the stator body, wherein each fluidic channel of the plurality of fluidic channels includes a restrictor element, wherein a flow of a fluid through the variable fluidic restrictor is selectively restricted based on a position of an external element coupled to the stator body is provided.
Utility
Autosampler seal pack for reducing a carryover percentage
10 May 22
A seal pack of a sample manager of a liquid chromatography system having a plurality of wash flow pathways fluidically connected to a central pathway that accommodates a sample needle, wherein a first wash flow pathway is vertically offset from a second wash flow pathway, such that a wash solution flows axially along an exterior surface of the sample needle in a vertical direction to wash the sample needle when flowing from the first wash flow pathway to the vertically offset second wash flow pathway, is provided.
Transcripts
2022 Q1
Earnings call transcript
3 May 22
2021 Q4
Earnings call transcript
1 Feb 22
2021 Q3
Earnings call transcript
2 Nov 21
2021 Q2
Earnings call transcript
3 Aug 21
2021 Q1
Earnings call transcript
5 May 21
2020 Q4
Earnings call transcript
2 Feb 21
2020 Q3
Earnings call transcript
27 Oct 20
2020 Q2
Earnings call transcript
28 Jul 20
2020 Q1
Earnings call transcript
28 Apr 20
2019 Q4
Earnings call transcript
4 Feb 20
Reddit threads
Daily Discussion Thread - May 3rd, 2022
3 May 22
Daily Discussion Thread - May 2nd, 2022
2 May 22
Twitter is looking to close a deal with Elon Musk get ur 🍿🍿 ready
25 Apr 22
What is the least volatile stock
6 Apr 22
Aftermath of the FED FOMC March 16 ( Quarter Basis Point Hike) & The Risks of 2022.
20 Mar 22
🎅🏻📉 Not looking good in Russia currently
3 Mar 22
NVDA and AMD - worth it now? Which one?
27 Feb 22
Daily Discussion Thread for February 09, 2022
9 Feb 22
Daily Discussion Thread - February 1st, 2022
1 Feb 22
Daily Discussion Thread - January 31st, 2022
31 Jan 22